The Division of Oncology is dedicated to developing multidisciplinary and lifesaving treatments for people worldwide who are affected by cancer. At the forefront of ground breaking treatments for cancer, our faculty is involved in more than 100 clinical trials to develop diagnostic and therapeutic approaches to various types of cancer.
New National Academy of Medicine members
Grace Lee, Crystal Mackall, Paul Mischel, Kari Nadeau, Anthony Oro and Krishna Shenoy are among the 100 members elected this year to the National Academy of Medicine.
Improving end-of-life care for kids
Research into medical decisions for children with terminal illnesses can be improved by sensitively tapping the expertise of families who have lost a child, according to Stanford Medicine experts.
Bertozzi research advances medicine
Bertozzi’s chemistry expertise advances research into cancer immunotherapies, tumor biology and COVID-19.
Hodgkin lymphoma pioneer Rosenberg dies
Rosenberg combined radiation and chemotherapy to treat Hodgkin lymphoma, revolutionizing cancer care. He taught at Stanford Medicine for more than 50 years.
Cancer tolerated by immune system
Cancer cells in the lymph nodes trick the immune system into tolerating their presence and welcoming metastasis, a pair of Stanford studies find. Blocking this process could stop cancer’s spread.
Conferences and Workshops
New courses are added regularly— please check back often
Non-Stanford CME Courses of Interest
17th Multidisciplinary Management of Cancers: A Case-Based Approach
Join the Mailing List
New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.